Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Currie

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 2, 2013
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesCraig J Currie, Chris D Poole, Marc Evans, et al.
Clinical and Experimental Rheumatology|May 19, 2016
Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across EuropeSarah E Holden, Craig J Currie, Martin Lennon, et al.
Diabetes, Obesity & Metabolism|May 8, 2018
Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysisChristopher Ll Morgan, Silvio E Inzucchi, Jorge Puelles, et al.
Journal of Crohn'S & Colitis|December 3, 2010
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitisChris D Poole, Mark P Connolly, Sandy Kildegaard Nielsen, et al.
Expert Review of Clinical Immunology|July 16, 2019
Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United KingdomLaura A Scott, Thomas R Berni, Ellen R Berni, et al.
Health and Quality of Life Outcomes|June 15, 2014
Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapyChris D Poole, Christian A Bannister, Jakob Nørgaard Andreasen, et al.
Current Medical Research and Opinion|July 28, 2006
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetesCraig J Currie, Christopher Ll Morgan, Chris D Poole, et al.
Current Medical Research and Opinion|July 12, 2018
Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United KingdomEllen Berni, Daniel Murphy, James Whitehouse, et al.
Journal of Crohn'S & Colitis|December 22, 2010
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trialMark P Connolly, Sandy K Nielsen, Craig J Currie, et al.
Current Medical Research and Opinion|October 4, 2005
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesRuth E Davis, Malcolm Morrissey, John R Peters, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|February 2, 2013
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesCraig J Currie, Chris D Poole, Marc Evans, et al.
Clinical and Experimental Rheumatology|May 19, 2016
Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across EuropeSarah E Holden, Craig J Currie, Martin Lennon, et al.
Diabetes, Obesity & Metabolism|May 8, 2018
Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysisChristopher Ll Morgan, Silvio E Inzucchi, Jorge Puelles, et al.
Journal of Crohn'S & Colitis|December 3, 2010
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitisChris D Poole, Mark P Connolly, Sandy Kildegaard Nielsen, et al.
Expert Review of Clinical Immunology|July 16, 2019
Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United KingdomLaura A Scott, Thomas R Berni, Ellen R Berni, et al.
Health and Quality of Life Outcomes|June 15, 2014
Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapyChris D Poole, Christian A Bannister, Jakob Nørgaard Andreasen, et al.
Current Medical Research and Opinion|July 28, 2006
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetesCraig J Currie, Christopher Ll Morgan, Chris D Poole, et al.
Current Medical Research and Opinion|July 12, 2018
Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United KingdomEllen Berni, Daniel Murphy, James Whitehouse, et al.
Journal of Crohn'S & Colitis|December 22, 2010
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trialMark P Connolly, Sandy K Nielsen, Craig J Currie, et al.
Current Medical Research and Opinion|October 4, 2005
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesRuth E Davis, Malcolm Morrissey, John R Peters, et al.
Pageof 10